Cargando…

Cell and Gene Therapy Trials: Are We Facing an ‘Evidence Crisis’?

Detalles Bibliográficos
Autores principales:	Abou-El-Enein, Mohamed, Hey, Spencer Phillips
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537560/ https://www.ncbi.nlm.nih.gov/pubmed/31193634 http://dx.doi.org/10.1016/j.eclinm.2019.01.015

Ejemplares similares

Adaptive trials, efficiency, and ethics
por: Hey, Spencer Phillips
Publicado: (2019)

Evolutionary ecology meets the antibiotic crisis: Can we control pathogen adaptation through sequential therapy?
por: Roemhild, Roderich, et al.
Publicado: (2019)

Critical Care Epidemiology and Research in the Face of a Pandemic: An Opportunity in a Crisis
por: Vijayaraghavan, Bharath Kumar Tirupakuzhi, et al.
Publicado: (2020)

Pandemic influenza: are we prepared to face our obligations?
por: Ehrenstein, Boris P
Publicado: (2008)

How is Brazil facing the crisis of Food and Nutrition Security during the COVID-19 pandemic?
por: de Carvalho, Carolina Abreu, et al.
Publicado: (2020)

Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals
por: Elsallab, Magdi, et al.
Publicado: (2020)

Adapting Mentoring in Times of Crisis: What We Learned from COVID-19
por: Tetzlaff, Julie, et al.
Publicado: (2022)

The health implications of financial crisis: A review of the evidence
por: Stuckler, David, et al.
Publicado: (2009)

Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials
por: Mookerjee, Rajeshwar P, et al.
Publicado: (2008)

Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)

Clinical trial management: a profession in crisis?
por: Mitchell, E. J., et al.
Publicado: (2022)

Acute stroke: we have the treatments and we have the evidence – we need to use them
por: Quinn, Terence J, et al.
Publicado: (2007)

Utilizing resources of neuropsychopharmacology to address the opioid overdose crisis
por: Phillips, Anthony G., et al.
Publicado: (2018)

Do we need new trials of procalcitonin-guided antibiotic therapy?
por: Lisboa, Thiago, et al.
Publicado: (2018)

Prioritizing sexual and reproductive health in the face of competing health needs: where are we going?
por: Otu, Akaninyene, et al.
Publicado: (2021)

The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis?
por: Fischer, Benedikt, et al.
Publicado: (2020)

Building Bridges to Address the Osteoporosis Crisis
por: El-Hajj Fuleihan, Ghada
Publicado: (2019)

How Did We Get Here: The Best Vaccines Ever Facing the Highest Public Hesitancy?
por: Ferreccio, Catterina
Publicado: (2023)

Accelerating Patients’ Access to Advanced Therapies in the EU
por: Elsanhoury, Ahmed, et al.
Publicado: (2017)

Are We Facing a New Colposcopic Practice in the HPV Vaccination Era? Opportunities, Challenges, and New Perspectives
por: Lukic, Ankica, et al.
Publicado: (2021)

The global crisis of multidrug resistance: how to face healthcare associated infections without effective antibiotics?
por: Mammina, Caterina
Publicado: (2013)

Changing patient preferences toward better trial recruitment: an ethical analysis
por: Al, Pepijn, et al.
Publicado: (2023)

How can behavioural science help us design better trials?
por: Gillies, Katie, et al.
Publicado: (2021)

We must not forget the most disadvantaged people facing the COVID-19 crisis
por: Mansuy, J.M., et al.
Publicado: (2020)

Telehealth is Face-to-Face Service Delivery
por: CASON, JANA
Publicado: (2017)

GDNF Therapy: Can We Make It Work?
por: Björklund, Anders
Publicado: (2021)

Drug shortage crisis in Sudan in times of COVID-19
por: Lucero-Prisno, Don Eliseo, et al.
Publicado: (2020)

Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell‐Based Interventions
por: Bauer, Gerhard, et al.
Publicado: (2018)

Providers and patients face-to-face: what is the time?
por: Racine, Andrew D.
Publicado: (2017)

Cost-effectiveness of Axicabtagene Ciloleucel and Tisagenlecleucel as Second-line or Later Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
por: Choe, Jee H., et al.
Publicado: (2022)

The imperative of evidence-based health workforce planning and implementation: lessons from nurses and midwives unemployment crisis in Ghana
por: Asamani, James Avoka, et al.
Publicado: (2020)

Management of immune checkpoint therapy for patients with cancer in the face of COVID-19
por: Shen, Chen, et al.
Publicado: (2020)

Leadership During Crisis: Lessons and Applications from the COVID-19 Pandemic
por: Kaul, Vivek, et al.
Publicado: (2020)

Covid-19 and drug therapy, what we learned
por: Provenzani, Alessio, et al.
Publicado: (2020)

Why We Should Consider Evidence-Based Treatment Options for Truncal Acne
por: Stein Gold, Linda, et al.
Publicado: (2021)

Neoadjuvant targeted therapy for advanced renal cell carcinoma: Where do we stand?
por: Grivas, Nikolaos K.
Publicado: (2019)

Breaking dogma for future therapy using stem cell - Where we have reached?
por: Verma, Rama S.
Publicado: (2016)

Commentary: Hepatocellular carcinoma after the Fontan operation: Are we paying attention?
por: Burkhart, Harold M., et al.
Publicado: (2020)

Hospital Planning for Contingency and Crisis Conditions: Crisis Standards of Care Lessons from COVID-19
por: Hick, John L., et al.
Publicado: (2022)

When Will the Pandemic End? Suggestions for US Communities to Manage Well-Being in the Face of COVID-19
por: Bliss, Clinton, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_trans6cfumtq6retn5j636qh97